|
|
|
|
| LEADER |
03105nmm a2200709 u 4500 |
| 001 |
EB002166290 |
| 003 |
EBX01000000000000001304069 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841298996
|
| 050 |
|
4 |
|a RS201.P65
|
| 100 |
1 |
|
|a Fujiwara, Tomoko
|e [editor]
|
| 245 |
0 |
0 |
|a Polymers in therapeutic delivery
|c Tomoko Fujiwara, editor, the University of Memphis, Memphis, Tennessee, X. Michael Liu, editor, Glaukos Corporation, San Clemente, California, Yuichi Ohya, editor, Kansai University, Osaka, Japan, Yongmei Wang, editor, the University of Memphis, Memphis, Tennessee
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 2020, 2020
|
| 300 |
|
|
|a 117 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Antineoplastic agents / Technological innovations
|
| 653 |
|
|
|a MEDICAL / Pharmacy / bisacsh
|
| 653 |
|
|
|a Drug receptors / Technological innovations
|
| 653 |
|
|
|a Colloids / therapeutic use
|
| 653 |
|
|
|a Polymeric drugs
|
| 653 |
|
|
|a Anhydrides / Therapeutic use
|
| 653 |
|
|
|a Aziridines / therapeutic use
|
| 653 |
|
|
|a Nanostructures / therapeutic use
|
| 653 |
|
|
|a Anhydrides / therapeutic use
|
| 653 |
|
|
|a Polymeric drug delivery systems
|
| 653 |
|
|
|a Polyethylene Glycols / therapeutic use
|
| 653 |
|
|
|a Polymeric drug delivery systems / Controlled release / Technological innovations
|
| 653 |
|
|
|a Drug delivery systems / Technological innovations
|
| 653 |
|
|
|a Nanocomposites (Materials) / Therapeutic use
|
| 653 |
|
|
|a Nanocomposites / therapeutic use
|
| 653 |
|
|
|a MEDICAL / Biotechnology / bisacsh
|
| 653 |
|
|
|a Polysaccharides / therapeutic use
|
| 653 |
|
|
|a Nanostructured materials / Therapeutic use
|
| 653 |
|
|
|a Polymers / Therapeutic use / Controlled release
|
| 653 |
|
|
|a Polyampholytes / Therapeutic use
|
| 653 |
|
|
|a Polysaccharides / Therapeutic use
|
| 653 |
|
|
|a Polymer colloids / Therapeutic use
|
| 653 |
|
|
|a Antineoplastic Agents
|
| 653 |
|
|
|a MEDICAL / Instruments & Supplies / bisacsh
|
| 653 |
|
|
|a Drug Delivery Systems
|
| 653 |
|
|
|a Liposomes / therapeutic use
|
| 653 |
|
|
|a Oligonucleotides / therapeutic use
|
| 653 |
|
|
|a Receptors, Drug
|
| 653 |
|
|
|a Liposomes / Therapeutic use
|
| 653 |
|
|
|a Polyethylene glycol / Therapeutic use
|
| 653 |
|
|
|a Polymers / therapeutic use
|
| 653 |
|
|
|a Oligonucleotides / Therapeutic use
|
| 653 |
|
|
|a Crosslinked polymers / Therapeutic use
|
| 653 |
|
|
|a Cell-mediated cytotoxicity / Analysis
|
| 653 |
|
|
|a Aziridines / Therapeutic use
|
| 700 |
1 |
|
|a Liu, X. Michael
|e [editor]
|
| 700 |
1 |
|
|a Ohya, Yuichi
|e [editor]
|
| 700 |
1 |
|
|a Wang, Yongmei
|e [editor]
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Polymer Chemistry
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a "Sponsored by the ACS Division of Polymer Chemistry, Inc.". - Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1021/bk-2020-1350
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615.1
|